전체 프로그램

ADCBiologicstaleServier Bio-Innovation LLCPhase 2

S227928 (S227928)

Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS)/AML · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4

임상시험 1상태 DISCONTINUED

AntibodystaleAmsterdam UMC, location VUmcPhase 2

pembrolizumab (Keytruda, SABR + pembrolizumab)

NSCLC, Stage I · NSCLC, Stage I

#NSCLCStageI#Antibody#Phase2#항체#면역항체+4

효능 ORR 41%임상시험 1상태 ACTIVE

AntibodystaleSanofiPhase 2

Tusamitamab ravtansine (SAR408701, SAR408701 (Tusamitamab ravtansine))

Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) · Non-squamous Non-small-cell Lung Cancer

#Non-squamousNon-small-cellLungCa#Antibody#Phase2#항체#면역항체+2

효능 ORR 66.7%임상시험 1상태 DISCONTINUED

AntibodystaleSamsung Bioepis Co., Ltd.Phase 3

proposed biosimilar to infliximab (SB2, SB2 (proposed biosimilar to infliximab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2

AntibodystaleRochePreclinical

proposed trastuzumab biosimilar (SB3, SB3 (proposed trastuzumab biosimilar))

Breast Neoplasms · HER2

#HER2#Antibody#Preclinical#항체#면역항체+3

효능 ORR 91.2%임상시험 1상태 DISCONTINUED

AntibodystaleSamsung Bioepis Co., Ltd.Approved

Adalimumab Biosimilar (SB5, SB5 (Adalimumab Biosimilar))

Plaque Psoriasis · Plaque Psoriasis

#PlaquePsoriasis#Antibody#Approved#항체#면역항체+2

효능 ORR 64%임상시험 1상태 ACTIVE

AntibodystaleAbbViePhase 3

proposed biosimilar to adalimumab (SB5, SB5 (proposed biosimilar to adalimumab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2

AntibodystaleInstitut Cancerologie de l'OuestPhase 2

durvalumab (Imfinzi, SBRT + Durvalumab)

Node; Prostate; Bone Metastases · Node; Prostate

#NodeProstate#Antibody#Phase2#항체#면역항체+5

AntibodystaleAbramson Cancer Center at Penn …Phase 1

atezolizumab (Tecentriq, SBRT + atezolizumab and bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase1#항체#면역항체+2

AntibodystaleZibo Municipal HospitalPhase 2

SBRT combined with Tislelizumab followed by Tislelizumab (SBRT combined with Tislelizumab followed by Tislelizumab)

NSCLC; Tislelizumab · FRα

#FR#Antibody#Phase2#항체#면역항체+4

#FR#CGT#Phase1#세포유전치료#CAR-T+4

SC-CAR4BRAIN (SC-CAR4BRAIN)

Diffuse Intrinsic Pontine Glioma; Diffuse Midline Glioma · FRα

AntibodystaleRochePhase 2

SC0191 + Bevacizumab (SC0191 + Bevacizumab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2

CGTBiologicstaleThe Affiliated Hospital of Qing…Phase 1

SCG142 TCR-T cells (SCG142 TCR-T cells)

Human Papillomavirus Associated Carcinomas; Cervical Cancer · Human Papillomavirus Associated Carcinom

#HumanPapillomavirusAssociatedCar#CGT#Phase1#세포유전치료#CAR-T+3

#SystemicLupusErythematosus#CGT#Phase1#세포유전치료#CAR-T+2

SCRI-CAR19v3 (SCRI-CAR19v3)

Systemic Lupus Erythematosus · Systemic Lupus Erythematosus

#CentralNervousSystemTumor#CGT#Phase1#세포유전치료#CAR-T+3

SCRI-CARB7H3 (SCRI-CARB7H3, SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel)

Central Nervous System Tumor; Diffuse Intrinsic Pontine Glioma · Central Nervous System Tumor

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3

SCRI-E2CAR_EGFRtv1 (SCRI-E2CAR_EGFRtv1)

Osteosarcoma · EGFR

CGTBiologicstaleShanghai Gynecologic Oncology G…Phase 1

SCT-001 CAR-T cells (SCT-001 CAR-T cells)

Ovarian Cancer; Fallopian Tube Carcinoma · Ovarian Cancer

#OvarianCancer#CGT#Phase1#세포유전치료#CAR-T+3

AntibodystaleJanssenApproved

daratumumab (Darzalex, SCT800 and Daratumumab)

Hemophilia A With Inhibitor · Hemophilia A With Inhibitor

#HemophiliaAWithInhibitor#Antibody#Approved#항체#면역항체+2

AntibodyBiologicstaleSeagen Inc.Phase 2

anti-huCD40 mAb (SGN-40, SGN-40 (anti-huCD40 mAb))

Leukemia, Lymphocytic, Chronic · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+5